← Back to Clinical Trials
Recruiting NCT05905705

Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy

Trial Parameters

Condition Treatment Resistant Depression
Sponsor Washington University School of Medicine
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 21 Years
Max Age 65 Years
Start Date 2023-03-07
Completion 2027-07-31
Interventions
Electroencephalography (EEG)Quantitative Measurements of Sleep Microstructure

Brief Summary

Electroconvulsive therapy (ECT) alleviates treatment-resistant depression (TRD) through repeated generalized seizures. The goal of this study is to evaluate how ECT impacts sleep-wake regulation and efficiency of information transfer in functional networks in different states of arousal.

Eligibility Criteria

Inclusion Criteria: * Referral for initial ECT index course for Treatment-Resistant Depression (TRD), unipolar major depressive disorder or bipolar depression. Historic failure of response or remission to at least two antidepressant medications of sufficient dose and duration will be used for TRD diagnostic. Exclusion Criteria: * Diagnoses of schizophrenia or schizoaffective disorders. * Subjects who are unable to tolerate the Dreem device for sleep recordings will be excluded from the study.

Related Trials